This month, 23andMe, the most prominent genetic home testing company, stopped offering anything more than ancestry results due to a warning by the FDA that its marketing claims about the value of their health-related reports were not backed by evidence regarding their accuracy.
The FDA was concerned that inaccurate results, including false positives or negatives, could lead some customers to seek treatment for diseases they don’t actually have, or to begin to medicate improperly, which has potentially fatal results.
A new analysis backs up that concern.
Read the full, original story: The Problem For 23andMe And The FDA: People Don’t Understand Genetic Test Results Or Their Implications